FDA approval of six-annual-dose HIV treatment
February 2, 2022Research and Development
ViiV Healthcare has announced the FDA approval of Cabenuva (cabotegravir, rilpivirine) for every-two-month dosing for
First European filing submission for multiple myeloma bispecific antibody
February 2, 2022Research and Development
Janssen has announced the submission of a Marketing Authorisation Application (MAA) to the EMA, seeking approval for off-the-shelf-bispecific antibody teclistamab, …
Technology on trial – the latest cogs in the clinical machine
February 1, 2022From the integration of social media to everyday life, to the seeping of AI into our daily lives, the past …
Access denied: Is Brexit spelling bedlam for UK clinical trials?
February 1, 2022Since Article 50 was triggered on the 29 March 2017, the UK’s pharmaceutical industry collectively held its breath, bracing itself …
Measles jab rate in England falls to ten percent below recommended rate
February 1, 2022Medical Communications
Over one in 10 school entry-age children in England are at risk of measles due to not receiving their vaccine …
AI technology has the potential for breast cancer diagnosis
February 1, 2022Manufacturing and Production
Academics at King’s College, London, and Guy’s and St Thomas’ NHS Foundation Trust, are using historical scans in a new …
WHO: COVID-19 hospital waste presents health threat
February 1, 2022Manufacturing and Production
The vast amount of waste produced in tackling the COVID-19 pandemic poses a threat to human and environmental health, warns …
RDIF, AstraZeneca and others invest in treatments for resistant arterial hypertension
February 1, 2022Medical Communications
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), AstraZeneca, and Unicorn Capital Partners, a biotech-specialised VC fund, announced …
FDA approves Vabysmo to treat vision-threatening retinal conditions
January 31, 2022Sales and Marketing
The FDA has approved vabysmo (faricimab-svoa) for the treatment of neovascular or “wet” age-related macular degeneration and diabetic macular edema. …
Almirall announces licensing agreement to accelerate antibody drug discovery
January 31, 2022Sales and Marketing
Almirall has announced a multi-target licensing agreement with Ablexis, focussed on licensing its AlivaMab Mouse technology, and a research collaboration …
Positive CHMP opinion for treatment of rare unpredictable disease
January 31, 2022Sales and Marketing
Blueprint Medicines has announced that the CHMP has adopted a positive opinion recommending to expand the current indication for AYVAKYT® …
CHMP recommends approval of dupixent for children with severe asthma
January 31, 2022Sales and Marketing
The EMA’s CHMP has adopted a positive opinion recommending the extension of the approval of Dupixent (dupilumab) for children with …
Supplemental NDA accepted for leukaemia treatment in China
January 28, 2022Medical Communications
BeiGene, focused on developing innovative and affordable medicines, announced that the Center for Drug Evaluation (CDE) of the China National …
India: DCGI approval for trialling of nasal COVID-19 vaccine
January 28, 2022Medical Communications
The Drugs Controller General of India (DCGI) has given permission to Bharat Biotech to conduct clinical trials for the use …
Launch of pioneering platform to accelerate mental health treatment discovery
January 28, 2022The clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, atai Life Sciences, has launched a platform …
The downfall of COVID-19 lies in new generation anti-viral drugs, says WHO
January 28, 2022Medical Communications
In a BBC News interview, WHO shared their views against easing pandemic restrictions, as new variants flare up anywhere until …
Oncology history: Immunocore claims first-ever FDA approval of melanoma drug
January 27, 2022Business Services
Immunocore has claimed a piece of history in biotech industry, becoming the first company to secure an FDA approval for …
Gilead combo therapy hit with FDA hold over serious adverse events
January 27, 2022Business Services
The FDA has placed a partial clinical hold on studies conducted by Gilead Sciences assessing the combination of magrolimab plus …
Face mask rules and COVID-19 passes end in England, care home restrictions ease
January 27, 2022Business Services
The government has announced that there will be no limit on the number of visitors to care homes in England. …
Medidata partners with Circuit Clinical to strengthen clinical trial capabilities
January 27, 2022Business Services
Medidata has announced a partnership with Circuit Clinical to strengthen its decentralised clinical trial (DCT) capabilities. Circuit Clinical has created …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
